These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 522933)

  • 1. [Effect of hemodialysis on the creatine kinase activity in inflammatory muscular diseases].
    Czyzewski K; Kominek-Zalewska M
    Neurol Neurochir Pol; 1979; 13(5):481-5. PubMed ID: 522933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hydrocortisone on the serum creatine kinase activity of muscles diseases.
    Cxyzewski K
    J Neurol; 1977 Nov; 216(4):283-7. PubMed ID: 72811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum enzymatic activity in neuromuscular diseases].
    Strumień M
    Neurol Neurochir Pol; 1975; 9(1):1-5. PubMed ID: 1121344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum enzymes in disease of skeletal muscle.
    Rosalki SB
    Clin Lab Med; 1989 Dec; 9(4):767-81. PubMed ID: 2686911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Creatine phosphokinase (CPK)--interpretation of the test results].
    Shoji S; Sugita H
    Nihon Rinsho; 1973; 31():1808-14. PubMed ID: 4582280
    [No Abstract]   [Full Text] [Related]  

  • 6. Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study.
    Zatz M; Frota-Pessoa O; Levy JA; Peres CA
    J Genet Hum; 1976 Jun; 24(2):153-68. PubMed ID: 965952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of the prednisolone test in myopathy diagnosis].
    Jörg J; Gerhard H
    Fortschr Neurol Psychiatr; 1984 Jan; 52(1):11-4. PubMed ID: 6698478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory changes in facioscapulohumeral muscular dystrophy.
    Molnár M; Diószeghy P; Mechler F
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(2):105-8. PubMed ID: 1834179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An examination of some factors influencing creatine kinase in the blood of patients with muscular dystrophy.
    Jackson MJ; Round JM; Newham DJ; Edwards RH
    Muscle Nerve; 1987 Jan; 10(1):15-21. PubMed ID: 3561434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative utility of serum creatine kinase versus serum aldolase in the evaluation of muscle disorders.
    Giesker D; Bowers GN
    Conn Med; 1979 Nov; 43(11):699-704. PubMed ID: 389542
    [No Abstract]   [Full Text] [Related]  

  • 11. [Case of polymyositis with unique creatine phosphokinase (CPK) isoenzyme patterns: appearance of marked CPK-MB and macro CPK].
    Kanoh T; Kokuryu H; Ushikubi F; Uchino H; Imai M
    Nihon Naika Gakkai Zasshi; 1982 Oct; 71(10):1451-4. PubMed ID: 7166667
    [No Abstract]   [Full Text] [Related]  

  • 12. A new method for the analysis of age trends in CPK levels with application to Duchenne muscular dystrophy.
    Lange K; Zatz M
    Hum Hered; 1979; 29(3):154-60. PubMed ID: 468274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Creatine phosphokinase: interpretation of the test results].
    Sugita H; Furukawa T; Chiba K
    Nihon Rinsho; 1969 Mar; ():Suppl:1072-7. PubMed ID: 4948291
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum creatine phosphokinase activity in Duchenne-type muscular dystrophy and carriers].
    Kato F; Takahashi K
    Iryo; 1968 Dec; 22(12):1386-91. PubMed ID: 5717705
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum CK-MB activity in progressive muscular dystrophy: is it of nosologic value?
    Vainzof M; Zatz M; Otto PA
    Am J Med Genet; 1985 Sep; 22(1):81-7. PubMed ID: 4050853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duchenne muscular dystrophy: comparison among different racial groups.
    Bortolini ER; Zatz M
    Am J Med Genet; 1987 Dec; 28(4):925-9. PubMed ID: 3688030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change of serum creatine phosphokinase activity after exercise in Duchenne type of progressive muscular dystrophy.
    Nakane K
    Nagoya Med J; 1972 Feb; 17(3):203-16. PubMed ID: 5050757
    [No Abstract]   [Full Text] [Related]  

  • 18. Human muscle carbonic anhydrase III (CA-III). Purification, immunohistochemical localization in the human skeletal muscle and its clinical application to the neuromuscular disease.
    Shima K
    Hokkaido Igaku Zasshi; 1984 Mar; 59(2):98-116. PubMed ID: 6430772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modification of the calculation of risk factors in women, possible carriers of Duchenne muscular dystrophy, based on CPK levels].
    Villamar López M; Azpeitia González J; Ayuso García C; Fernández García E; Benítez Ortiz J
    An Esp Pediatr; 1992 Sep; 37(3):191-4. PubMed ID: 1443913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscular dystrophy. Part I: Serum enzymes in the Duchenne muscular dystrophy and other neuromuscular disorders.
    Narayanan I; Ramakrishna Rao P; Balakrishnan S; Subrahmanyam K
    Indian J Med Res; 1974 Apr; 62(4):598-604. PubMed ID: 4435868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.